Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 AUD | -4.26% | -4.26% | +309.09% |
Apr. 30 | Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury | MT |
Apr. 18 | Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024 |
Sales 2022 | 1.09 1.66 | Sales 2023 | 1.43 2.16 | Capitalization | 4.37M 6.61M |
---|---|---|---|---|---|
Net income 2022 | -3M -4.54M | Net income 2023 | -7M -10.59M | EV / Sales 2022 | 9,367,032 x |
Net cash position 2022 | 10.82M 16.37M | Net cash position 2023 | 3.71M 5.61M | EV / Sales 2023 | 461,207 x |
P/E ratio 2022 |
-4.5
x | P/E ratio 2023 |
-0.56
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 30.03% |
Latest transcript on Nyrada Inc.
1 day | -4.26% | ||
1 week | -4.26% | ||
Current month | -4.26% | ||
1 month | -8.16% | ||
3 months | +309.09% | ||
6 months | +328.57% | ||
Current year | +309.09% |
Managers | Title | Age | Since |
---|---|---|---|
James Bonnar
CEO | Chief Executive Officer | - | 18-01-31 |
Founder | - | 17-08-28 | |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 17-08-28 | |
Ruediger Weseloh
BRD | Director/Board Member | - | 19-05-31 |
Marcus Frampton
BRD | Director/Board Member | 44 | 19-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.09 | -4.26% | 1,189,578 |
24-05-02 | 0.094 | +2.17% | 460,132 |
24-05-01 | 0.092 | -2.13% | 408,496 |
24-04-30 | 0.094 | -1.05% | 618,536 |
24-04-29 | 0.095 | +1.06% | 558,347 |
Delayed Quote Australian S.E., May 03, 2024 at 01:59 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+309.09% | 10.68M | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- NYR Stock